Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study
These conditions can cause discomfort but are usually manageable with dietary adjustments and hydration
Expanding affordable access to antiobesity medications is an important step toward better population health
However, the data suggest it might help people with ALS live longer
In fact, a 2025 study published in JAMA cites steep list prices (over $1000 a month) and spotty insurance coverage as top reasons why most people seeking to lose weight quit taking meds like Ozempic or Vaxenda within a year
A single medication that addresses the reward dysregulation underlying both could simplify treatment, improve compliance (patients are motivated by visible weight loss), and reduce the sense of being pulled in multiple directions that so many patients describe
